Traditional and Computational Screening of Non-Toxic Peptides and Approaches to Improving Selectivity

  title={Traditional and Computational Screening of Non-Toxic Peptides and Approaches to Improving Selectivity},
  author={Alberto A Robles-Loaiza and Edgar A Pinos-Tamayo and Bruno Mendes and Josselyn A. Ortega-Pila and Carolina Proa{\~n}o-Bola{\~n}os and Fabien Plisson and C{\'a}tia Teixeira and Paula A C Gomes and Jos{\'e} Rafael Almeida},
Peptides have positively impacted the pharmaceutical industry as drugs, biomarkers, or diagnostic tools of high therapeutic value. However, only a handful have progressed to the market. Toxicity is one of the main obstacles to translating peptides into clinics. Hemolysis or hemotoxicity, the principal source of toxicity, is a natural or disease-induced event leading to the death of vital red blood cells. Initial screenings for toxicity have been widely evaluated using erythrocytes as the gold… 

Figures and Tables from this paper

Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment.

To the 80th Anniversary of Gramicidin C Сreation: From the Study of the Asymmetry of Bacterial Molecules to the Discovery of Antimicrobial Peptides

G gramicidin C, obtained at the dawn of the era of antibiotics, became a harbinger of the birth of a fundamentally new and promising antimicrobial strategy.

The latest guidance on the simultaneous design of virtually active and non-hemolytic peptides.

Peptide discovery is a very active research area. Computational methods have become an essential part of the process of designing peptides with desired properties. However, such methods have several

Simulation Study of the Effect of Antimicrobial Peptide Associations on the Mechanism of Action with Bacterial and Eukaryotic Membranes

Antimicrobial peptides (AMPs) can be directed to specific membranes based on differences in lipid composition. In this study, we performed atomistic and coarse-grained simulations of different

In Silico Prediction of Anti-Infective and Cell-Penetrating Peptides from Thalassophryne nattereri Natterin Toxins

The results demonstrate that toxins form a natural biotechnological platform in drug discovery, and the presence of CPP and AMP sequences in toxin families opens new possibilities in toxin biochemistry research.



In Silico Approach for Predicting Toxicity of Peptides and Proteins

A web server, ToxinPred has been developed, which would be helpful in predicting toxicity or non-toxicity of peptides, minimum mutations in peptides for increasing or decreasing their toxicity, and toxic regions in proteins.

Peptide toxicity prediction.

Both wet lab and dry lab approaches used to optimize peptide toxicity and more emphasis has been given to describe the in silico method, ToxinPred, to predict the toxicity of peptide and about how to design a peptide or protein with desired toxicity by mutating minimum number of amino acids.

In silico design and optimization of selective membranolytic anticancer peptides

The results of the present study advocate for the applicability of machine learning models and evolutionary algorithms to design and optimize novel synthetic anticancer peptides with reduced hemolytic liability and increased cell-type selectivity.

Machine learning-guided discovery and design of non-hemolytic peptides

This work developed machine learning models and outlier detection methods that ensure robust predictions for the discovery of AMPs and the design of novel peptides with reduced hemolytic activity, and led to the discovery and design of 34 high-confidence non-hemolytic natural AMPs.

Therapeutic peptides for chemotherapy: trends and challenges for advanced delivery systems.

HAPPENN is a novel tool for hemolytic activity prediction for therapeutic peptides which employs neural networks

This study leverages advances in machine learning research to produce a novel artificial neural network classifier for the prediction of hemolytic activity from a peptide’s primary sequence, achieving best-in-class performance.

In silico Approaches for the Design and Optimization of Interfering Peptides Against Protein–Protein Interactions

The most recent advances in the field of in silico approaches for the design of interfering peptides against PPIs will be reviewed and the future perspective of the field and its advantages and limitations will be pinpointed.

Machine intelligence in peptide therapeutics: A next‐generation tool for rapid disease screening

Overall, it is shown that using ML models in peptide research can streamline the development of targeted peptide therapies and avoid the common pitfalls and challenges of using ML approaches for peptide therapeutics.

Computational peptidology: a new and promising approach to therapeutic peptide design.

A newly rising subfield called computational peptidology that focuses on the use of computational and theoretical approaches to treat peptide-related problems is comprehensively reviewed on the design and discovery of peptide agents targeting protein-protein interactions.